Sanofi
-
Potential losses exceed $300 billion! Nearly 200 drugs are facing a patent cliff
For more reports, please follow DrugTimes
-
【Product for Licensing】T-cell engager (TCE), bispecific, trispecific, and multispecific products are available
If you are interested in similar assets, please contact DrugTimes BD Team at BD@drugtimes.cn asap. Many thanks!~
-
Split! Sanofi may book $16.4 billion
For more reports, please follow DrugTimes. Many thanks!
-
In four months, Sanofi lost $80 million, but it’s worth it
Drug discovery and development is not easy. We pay respect to all the heroes
-
TOP PHARMAS BY 2024 PIPELINE SIZE
For more info, please visit https://www.drugtimes.cn/english-content
